{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"623d897a12cc93bd9e8c2dbc5ed3f535372593424a1b8e348105730c0d0706c5","attributes":{"feedName":"fda","feedSource":"fda","title":"PharMEDium Services, LLC Issues Voluntary Nationwide Recall of 0.5 mg/mL HYDROmorphone HCl in 0.9% Sodium Chloride 1 mL in 3 mL BD Syringe Due to Presence of Sulfite","description":"PharMEDium Services, LLC is voluntarily recalling 45 lots of 0.5 mg/mL HYDROmorphone HCl in 0.9% Sodium Chloride 1 mL in 3 mL BD Syringe to the user level. The product is being recalled because PharMEDiumâ€™s electronic customer ordering system stated it is sulfite-free, but the product contains sulfi","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pharmedium-services-llc-issues-voluntary-nationwide-recall-05-mgml-hydromorphone-hcl-09-sodium","publicationDate":"2019-06-28T04:00:00.000Z","state":"sent","affected":[],"allergens":["sulfites"],"audience":["professionals"],"categories":["drugs"],"contaminants":[],"distribution":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"risk":"possible","token":"5d9e68df8b079e002a251fd1"}}}